Blood-based biomarkers and the new landscape of Alzheimer’s research

For much of the past century, Alzheimer’s disease has been one of medicine’s most daunting frontiers – biologically complex, devastating in impact, and difficult to diagnose early. Conventional diagnostic methods like positron…